CAMBRIDGE, Mass., Oct. 31 /PRNewswire/ -- Xanthus Life Sciences, Inc., a privately-held oncology drug development company, today announced that it will be presenting at the following upcoming investment conferences in November:
* Richard T. Dean, Ph.D., Chief Executive Officer, will present at the Mass Opportunities Investment Conference on November 3, 2005 at 3:40pm at the Hilton Logan Airport, Boston * John A. McCarthy, Jr., Senior Vice President & Chief Financial Officer, will present at the Rodman & Renshaw Techvest 7th Annual Healthcare Conference on November 9, 2005 at 3:10pm at the Palace Hotel in New York * Richard T. Dean, Ph.D., Chief Executive Officer, will present at the CIBC World Markets Healthcare Conference on November 9, 2005 at 4:00pm at the Waldorf-Astoria in New York
A live audio webcast of Dr. Dean’s presentation at the CIBC World Markets Healthcare Conference will be available on the Company’s website located at http://www.xanthus.com. A replay of the presentation will be posted on the Xanthus website approximately thirty minutes after the event.
About Xanthus
Xanthus is developing a portfolio of novel, clinical-stage, small-molecule oncology candidates. Xanthus’ management team has an accomplished track record in all aspects of drug development, from discovery and development through regulatory approval and commercialization. The Company is applying its expertise both to advance its product portfolio and to expand it into indications of unmet medical need beyond oncology. More information about Xanthus is available on the Net: http://www.xanthus.com
Xanthus Life Sciences, Inc.
CONTACT: Kari Watson of MacDougall Biomedical Communications, Inc., +1-508-647-0209, kwatson@macbiocom.com; or John A. McCarthy, Jr., SVP & CFO ofXanthus Life Sciences, Inc., +1-617-225-0522, ext. 125,john.mccarthy@xanthus.com
Web site: http://www.xanthus.com//
